Cotiviti Holdings (NYSE: COTV) is one of 20 publicly-traded companies in the “Medical Software & Technology Services” industry, but how does it contrast to its rivals? We will compare Cotiviti Holdings to similar businesses based on the strength of its dividends, risk, institutional ownership, earnings, profitability, analyst recommendations and valuation.
Earnings & Valuation
This table compares Cotiviti Holdings and its rivals revenue, earnings per share and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Cotiviti Holdings||$625.16 million||$48.85 million||32.75|
|Cotiviti Holdings Competitors||$413.57 million||-$24.55 million||396.69|
This table compares Cotiviti Holdings and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Cotiviti Holdings Competitors||-14.89%||-8.49%||-0.27%|
Insider and Institutional Ownership
89.0% of Cotiviti Holdings shares are held by institutional investors. Comparatively, 66.5% of shares of all “Medical Software & Technology Services” companies are held by institutional investors. 15.8% of Cotiviti Holdings shares are held by company insiders. Comparatively, 21.4% of shares of all “Medical Software & Technology Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Risk & Volatility
Cotiviti Holdings has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, Cotiviti Holdings’ rivals have a beta of 1.39, indicating that their average stock price is 39% more volatile than the S&P 500.
This is a breakdown of recent ratings and recommmendations for Cotiviti Holdings and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Cotiviti Holdings Competitors||84||433||820||13||2.56|
Cotiviti Holdings presently has a consensus price target of $41.29, suggesting a potential upside of 29.95%. As a group, “Medical Software & Technology Services” companies have a potential upside of 19.36%. Given Cotiviti Holdings’ stronger consensus rating and higher probable upside, equities analysts clearly believe Cotiviti Holdings is more favorable than its rivals.
Cotiviti Holdings beats its rivals on 9 of the 13 factors compared.
Cotiviti Holdings Company Profile
Cotiviti Holdings, Inc. is a provider of analytics-driven payment accuracy solutions. The Company focuses primarily on the healthcare sector. The Company operates through two segments: Healthcare, and Global Retail and Other. Through its Healthcare segment, the Company offers prospective and retrospective claims accuracy solutions to healthcare payers in the United States. The Company also provides analytics-based solutions unrelated to its healthcare payment accuracy solutions in the United States. Through its Global Retail and Other segment, the Company provides retrospective claims accuracy solutions to retailers primarily in the United States, Canada and the United Kingdom, as well as solutions that manage payment networks for a range of clients. The Company leverages its technology platform, configurable analytics, information assets and expertise in healthcare reimbursement to help its clients develop their claims payment accuracy.
Receive News & Ratings for Cotiviti Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.